Bank of New York Mellon Corp cut its holdings in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 1.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,511,167 shares of the real estate investment trust’s stock after selling 74,166 shares during the period. Bank of New York Mellon Corp owned approximately 0.93% of Healthpeak Properties worth $131,981,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. HM Payson & Co. bought a new position in shares of Healthpeak Properties in the 3rd quarter worth about $25,000. Avior Wealth Management LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $37,000. Groupama Asset Managment bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $37,000. Capital Performance Advisors LLP bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $42,000. Finally, Wiser Advisor Group LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $42,000. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Price Performance
Healthpeak Properties stock opened at $20.44 on Friday. Healthpeak Properties, Inc. has a 12 month low of $16.49 and a 12 month high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The business’s 50 day simple moving average is $20.18 and its 200 day simple moving average is $21.36. The company has a market cap of $14.30 billion, a price-to-earnings ratio of 58.39, a PEG ratio of 2.17 and a beta of 1.15.
Healthpeak Properties Increases Dividend
Wall Street Analyst Weigh In
A number of analysts recently commented on DOC shares. Wedbush decreased their target price on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Royal Bank of Canada boosted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Scotiabank decreased their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday. Finally, Robert W. Baird decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average price target of $23.92.
Check Out Our Latest Stock Report on Healthpeak Properties
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- Should You Invest in Penny Stocks?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- The How and Why of Investing in Gold Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to Read Stock Charts for Beginners
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.